Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $925.12 million
- Book Value:
- Revenue TTM:
- $357.87 million
- Operating Margin TTM:
- Gross Profit TTM:
- $141.00 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Accolade Inc had its IPO on 2020-07-02 under the ticker symbol ACCD.
The company operates in the Healthcare sector and Health Information Services industry. Accolade Inc has a staff strength of 2,350 employees.
Shares of Accolade Inc opened at $13.24 at the start of the last trading session i.e. 2023-03-29.
The stocks traded within a range of $13.03 - $13.62, and closed at $13.37.
This is a +2.37% increase from the previous day's closing price.
A total volume of 558,972 shares were traded at the close of the day’s session.
In the last one week, shares of Accolade Inc have increased by +5.44%.
Accolade Inc's Key Ratios
Accolade Inc has a market cap of $925.12 million, indicating a price to book ratio of 1.3171 and a price to sales ratio of 1.7206.
In the last 12-months Accolade Inc’s revenue was $357.87 million with a gross profit of $141.00 million and an EBITDA of $-123888000. The EBITDA ratio measures Accolade Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Accolade Inc’s operating margin was -47.26% while its return on assets stood at -9.71% with a return of equity of -72.77%.
In Q3.6666666666667, Accolade Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 9%.
Accolade Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-7.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Accolade Inc’s profitability.
Accolade Inc stock is trading at a EV to sales ratio of 1.8712 and a EV to EBITDA ratio of -1.8762. Its price to sales ratio in the trailing 12-months stood at 1.7206.
Accolade Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $913.79 million
- Total Liabilities
- $116.62 million
- Operating Cash Flow
- Capital Expenditure
- $3.18 million
- Dividend Payout Ratio
Accolade Inc ended 2023 with $913.79 million in total assets and $0 in total liabilities. Its intangible assets were valued at $913.79 million while shareholder equity stood at $485.95 million.
Accolade Inc ended 2023 with $0 in deferred long-term liabilities, $116.62 million in other current liabilities, 7000.00 in common stock, $-923861000.00 in retained earnings and $278.19 million in goodwill. Its cash balance stood at $325.64 million and cash and short-term investments were $325.64 million. The company’s total short-term debt was $7,392,000 while long-term debt stood at $281.91 million.
Accolade Inc’s total current assets stands at $366.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $20.48 million compared to accounts payable of $9.99 million and inventory worth $0.
In 2023, Accolade Inc's operating cash flow was $-1911000.00 while its capital expenditure stood at $3.18 million.
Comparatively, Accolade Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Accolade Inc stock is currently trading at $13.37 per share. It touched a 52-week high of $19.39 and a 52-week low of $19.39. Analysts tracking the stock have a 12-month average target price of $13.19.
Its 50-day moving average was $11.71 and 200-day moving average was $10.27 The short ratio stood at 4.66 indicating a short percent outstanding of 0%.
Around 242.3% of the company’s stock are held by insiders while 8195.9% are held by institutions.
Frequently Asked Questions About Accolade Inc
Similar Industry Stocks (Health Information Services)
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees’ families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.